Jonathan M. Gall, Ph.D. - Publications

Affiliations: 
2012 Boston University, Boston, MA, United States 
Area:
Medicine and Surgery, Molecular Biology

12/22 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2017 Wang Z, Gall JM, Bonegio R, Havasi A, Illanes K, Schwartz JH, Borkan SC. Correction for Wang et al., "Nucleophosmin, a Critical Bax Cofactor in Ischemia-Induced Cell Death". Molecular and Cellular Biology. 37. PMID 28899998 DOI: 10.1128/MCB.00258-17  0.48
2015 Gall JM, Wang Z, Bonegio RG, Havasi A, Liesa M, Vemula P, Borkan SC. Conditional knockout of proximal tubule mitofusin 2 accelerates recovery and improves survival after renal ischemia. Journal of the American Society of Nephrology : Jasn. 26: 1092-102. PMID 25201884 DOI: 10.1681/ASN.2014010126  0.48
2013 Wang Z, Gall JM, Bonegio R, Havasi A, Illanes K, Schwartz JH, Borkan SC. Nucleophosmin, a critical Bax cofactor in ischemia-induced cell death. Molecular and Cellular Biology. 33: 1916-24. PMID 23459946 DOI: 10.1128/MCB.00015-13  0.48
2013 Havasi A, Haegele JA, Gall JM, Blackmon S, Ichimura T, Bonegio RG, Panchenko MV. Histone acetyl transferase (HAT) HBO1 and JADE1 in epithelial cell regeneration. The American Journal of Pathology. 182: 152-62. PMID 23159946 DOI: 10.1016/j.ajpath.2012.09.017  0.48
2012 Gall JM, Wang Z, Liesa M, Molina A, Havasi A, Schwartz JH, Shirihai O, Borkan SC, Bonegio RG. Role of mitofusin 2 in the renal stress response. Plos One. 7: e31074. PMID 22292091 DOI: 10.1371/Journal.Pone.0031074  0.48
2011 Gall JM, Wong V, Pimental DR, Havasi A, Wang Z, Pastorino JG, Bonegio RG, Schwartz JH, Borkan SC. Hexokinase regulates Bax-mediated mitochondrial membrane injury following ischemic stress. Kidney International. 79: 1207-16. PMID 21430642 DOI: 10.1038/ki.2010.532  0.48
2011 Wang Z, Gall JM, Bonegio RG, Havasi A, Hunt CR, Sherman MY, Schwartz JH, Borkan SC. Induction of heat shock protein 70 inhibits ischemic renal injury. Kidney International. 79: 861-70. PMID 21270764 DOI: 10.1038/ki.2010.527  0.48
2010 Wang Z, Havasi A, Gall J, Bonegio R, Li Z, Mao H, Schwartz JH, Borkan SC. GSK3beta promotes apoptosis after renal ischemic injury. Journal of the American Society of Nephrology : Jasn. 21: 284-94. PMID 20093356 DOI: 10.1681/ASN.2009080828  0.48
2009 Wang Z, Havasi A, Gall JM, Mao H, Schwartz JH, Borkan SC. Beta-catenin promotes survival of renal epithelial cells by inhibiting Bax. Journal of the American Society of Nephrology : Jasn. 20: 1919-28. PMID 19696224 DOI: 10.1681/ASN.2009030253  0.48
2009 Havasi A, Wang Z, Gall JM, Spaderna M, Suri V, Canlas E, Martin JL, Schwartz JH, Borkan SC. Hsp27 inhibits sublethal, Src-mediated renal epithelial cell injury. American Journal of Physiology. Renal Physiology. 297: F760-8. PMID 19553351 DOI: 10.1152/ajprenal.00052.2009  0.48
2007 Lee RJ, Fang Q, Davol PA, Gu Y, Sievers RE, Grabert RC, Gall JM, Tsang E, Yee MS, Fok H, Huang NF, Padbury JF, Larrick JW, Lum LG. Antibody targeting of stem cells to infarcted myocardium. Stem Cells (Dayton, Ohio). 25: 712-7. PMID 17138964 DOI: 10.1634/Stemcells.2005-0602  0.48
2006 Chan JK, Hamilton CA, Cheung MK, Karimi M, Baker J, Gall JM, Schulz S, Thorne SH, Teng NN, Contag CH, Lum LG, Negrin RS. Enhanced killing of primary ovarian cancer by retargeting autologous cytokine-induced killer cells with bispecific antibodies: a preclinical study. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 12: 1859-67. PMID 16551871 DOI: 10.1158/1078-0432.Ccr-05-2019  0.48
Low-probability matches
2019 Gall J, Choi T, Riddle V, Van Wart S, Gibbons JA, Seroogy J. A Phase 1 Study of Intravenous Plazomicin in Healthy Adults to Assess Potential Effects on the QT/QTc Interval, Safety, and Pharmacokinetics. Clinical Pharmacology in Drug Development. PMID 30650259 DOI: 10.1002/cpdd.653  0.01
2019 Komirenko A, Gall J, Hershberger E, Smith A, Connolly L, McKinnell J. 583 Critical Care Medicine. 47: 272. DOI: 10.1097/01.ccm.0000551335.08074.a1  0.01
2018 Murosko D, Audi Z, He Y, Gall J, Zheng D, Rainer T, Ludomirsky A, Wingerter S. Acceptance and Perceived Benefits of Conference-Based Storytelling Session on Pediatric Resident Wellness Academic Pediatrics. 18: e38. DOI: 10.1016/j.acap.2018.04.104  0.01
2017 McKinnell JA, Connolly LE, Pushkin R, Jubb AM, O’Keeffe B, Serio AW, Smith A, Gall J, Riddle V, Krause KM, Pogue JM. Improved Outcomes with Plazomicin (PLZ) Compared with Colistin (CST) in Patients with Bloodstream Infections (BSI) Caused by Carbapenem-resistant Enterobacteriaceae (CRE): Results from the CARE Study Open Forum Infectious Diseases. 4: S531-S531. DOI: 10.1093/OFID/OFX163.1383  0.01
2007 Jackson DC, Taylor SE, Asare VS, Villarnovo D, Gall JM, Reese SA. Comparative shell buffering properties correlate with anoxia tolerance in freshwater turtles. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology. 292: R1008-15. PMID 17008457 DOI: 10.1152/ajpregu.00519.2006  0.01
2006 Grabert RC, Cousens LP, Smith JA, Olson S, Gall J, Young WB, Davol PA, Lum LG. Human T cells armed with Her2/neu bispecific antibodies divide, are cytotoxic, and secrete cytokines with repeated stimulation. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 12: 569-76. PMID 16428502 DOI: 10.1158/1078-0432.CCR-05-2005  0.01
2005 Gall JM, Davol PA, Grabert RC, Deaver M, Lum LG. T cells armed with anti-CD3 x anti-CD20 bispecific antibody enhance killing of CD20+ malignant B cells and bypass complement-mediated rituximab resistance in vitro. Experimental Hematology. 33: 452-9. PMID 15781336 DOI: 10.1016/j.exphem.2005.01.007  0.01
2005 Chan JK, Hamilton CA, Cheung MK, Karimi M, Baker J, Gall JM, Lum LG, Schulz S, Thorne SH, Teng NN, Contag CH, Negrin RS. Immunotherapy of Primary Ovarian Cancer Using Autologous Cytokine Induced Killer Cells Retargeted with Bispecific Antibodies: A Preclinical Study. Blood. 106: 2379-2379. DOI: 10.1182/Blood.V106.11.2379.2379  0.01
2004 Lum LG, Davol PA, Sievers RE, Grabert RC, Fang Q, Gall JM, Yee MS, Larrick JW, Lee RJ. Human Stem Cells Armed with Bispecific Antibodies Home to Injury-Specific Molecules in Myocardial Infarcts in Nude Rats. Blood. 104: 2697-2697. DOI: 10.1182/Blood.V104.11.2697.2697  0.01
2004 Davol PA, Gall JM, Grabert RC, Young WB, Cummings FJ, Rathore R, Colvin GA, Elfenbein GJ, Lum LG. Infusions of T Cells Armed with Anti-CD3 x Anti-Her2/neu Bispecific Antibody Modulate In Vivo Patient Immune Responses in Phase I Clinical Trials for Breast and Hormone Refractory Prostate Cancers. Blood. 104: 1349-1349. DOI: 10.1182/BLOOD.V104.11.1349.1349  0.01
Hide low-probability matches.